Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of Icatibant in Japanese Subjects With Acute Attacks of Hereditary Angioedema.

NCT03888755 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT03888755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03888755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of Icatibant in Japanese Subjects With Acute Attacks of Hereditary Angioedema.
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
March 18, 2015
Completion date
February 12, 2016
Enrollment
8 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema (hae)